Skip to main content
Profound Medical Corp. logo

Profound Medical Corp. — Investor Relations & Filings

Ticker · PROF TSX Manufacturing
Open in API
Filings indexed 659 across all filing types
Latest filing 2024-12-06 Regulatory Filings
Country CA Canada
Listing TSX PROF

About Profound Medical Corp.

https://profoundmedical.com/

Profound Medical Corp. is a commercial-stage medical technology company specializing in incision-free ablative therapies. Its core product is TULSA-PRO®, a therapeutic platform designed for the treatment of localized prostate cancer, radiorecurrent prostate cancer, and benign prostatic hyperplasia (BPH). TULSA-PRO utilizes a robotically controlled, transurethral ultrasound ablation procedure guided by real-time Magnetic Resonance (MR) imaging. This system employs closed-loop temperature feedback to ensure precise and customizable tissue ablation, prioritizing patient safety and minimizing complications. The technology merges MR imaging, thermal ultrasound, and robotics to offer a durable and accurate treatment delivery method.

Recent filings

Filing Released Lang Actions
Consent letter of underwriters' legal counsel.pdf
Regulatory Filings Classification · 60% confidence The document is a legal opinion/consent letter from Osler, Hoskin & Harcourt LLP to Canadian securities regulators regarding a supplement to a base shelf prospectus. It is not a financial report, earnings release, or management discussion, nor is it a dividend or board change announcement. It is part of a regulatory filing (prospectus supplement) and does not announce financing terms itself. Therefore it falls into the fallback category for miscellaneous regulatory filings (RNS).
2024-12-06 English
News release - English.pdf
Regulatory Filings
2024-12-06 English
Marketing materials (other than specified derivative) - English.pdf
Share Issue/Capital Change Classification · 87% confidence The document is a prospectus-style announcement detailing the terms of a treasury offering of common shares, including offering size, price mechanism, use of proceeds, over-allotment option, listing information, and closing date. This constitutes a new share issuance/capital change rather than an earnings release or management report. Therefore, it fits the 'Share Issue/Capital Change' category (Code: SHA).
2024-12-06 English
Draft shelf prospectus supplement – English.pdf
Capital/Financing Update Classification · 89% confidence The document is a preliminary prospectus supplement to a short form base shelf prospectus, detailing an underwritten offering of common shares, pricing, underwriting arrangements, over-allotment options and other terms of the new share issuance. This is a financing transaction rather than a regular financial report or meeting material. It fits the Capital/Financing Update category (CAP) rather than a simple announcement (RPA) or shareholding notification. Thus, the correct classification is CAP.
2024-12-05 English
News release - English.pdf
Capital/Financing Update Classification · 93% confidence The document is a press release announcing Profound Medical’s intention to conduct a public offering of common shares, detailing underwriting, prospectus filings, use of proceeds, and offering terms. This is clearly a financing/capital update rather than an AGM, earnings release, or other category.
2024-12-05 English
News release - English.pdf
Regulatory Filings Classification · 35% confidence The document is a corporate press release announcing a co-sales and co-marketing agreement between Profound Medical and Siemens Healthineers. It is not an annual or interim report, audit, earnings release, proxy statement, dividend notice, management change, or other specific filing type. It is a general news announcement of a strategic partnership, which does not fit specialized categories such as financing update or M&A, so it falls into the fallback category of general regulatory/press filings (RNS).
2024-12-02 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.